chr10-71694260-G-A
Variant summary
Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PVS1PP5_Very_Strong
The NM_022124.6(CDH23):c.2289+1G>A variant causes a splice donor change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000131 in 1,608,818 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_022124.6 splice_donor
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CDH23 | NM_022124.6 | c.2289+1G>A | splice_donor_variant | ENST00000224721.12 | NP_071407.4 | |||
CDH23 | NM_001171930.2 | c.2289+1G>A | splice_donor_variant | NP_001165401.1 | ||||
CDH23 | NM_001171931.2 | c.2289+1G>A | splice_donor_variant | NP_001165402.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CDH23 | ENST00000224721.12 | c.2289+1G>A | splice_donor_variant | 5 | NM_022124.6 | ENSP00000224721 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 152048Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000204 AC: 5AN: 245252Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 133304
GnomAD4 exome AF: 0.0000130 AC: 19AN: 1456770Hom.: 0 Cov.: 31 AF XY: 0.0000110 AC XY: 8AN XY: 724554
GnomAD4 genome AF: 0.0000132 AC: 2AN: 152048Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74244
ClinVar
Submissions by phenotype
not provided Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Jul 10, 2023 | Published functional studies confirm the variant results in aberrant splicing and protein truncation (Aparisi et al., 2013); Canonical splice site variant predicted to result in a null allele in a gene for which loss-of-function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 18429043, 31546658, 19683999, 33297549, 12075507, 15353998, 31589614, 25525159, 32467589, 23451239) - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 29, 2024 | This sequence change affects a donor splice site in intron 21 of the CDH23 gene. RNA analysis indicates that disruption of this splice site induces altered splicing and may result in an absent or disrupted protein product. This variant is present in population databases (rs769433759, gnomAD 0.004%). Disruption of this splice site has been observed in individuals with Usher syndrome (PMID: 12075507, 18429043, 19683999). This variant is also known as IVS20+1G>A. ClinVar contains an entry for this variant (Variation ID: 504507). Studies have shown that disruption of this splice site alters mRNA splicing and is expected to lead to the loss of protein expression (PMID: 23451239). For these reasons, this variant has been classified as Pathogenic. - |
Pituitary adenoma 5, multiple types Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Mar 12, 2024 | - - |
Usher syndrome type 1 Pathogenic:1
Pathogenic, no assertion criteria provided | clinical testing | Natera, Inc. | Sep 16, 2020 | - - |
Usher syndrome type 1D Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Molecular Diagnostics Laboratory, M Health Fairview: University of Minnesota | Sep 12, 2016 | - - |
Rare genetic deafness Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | May 05, 2016 | The c.2289+1G>A variant in CDH23 has been reported in several individuals with U sher syndrome, including at least 2 compound heterozygotes and 1 homozygote (Ast uto 2002, Pennings 2004, Oshima 2008, Jaijo 2009, Aparisi 2013). This variant ha s been identified in 3/60698 European chromosomes by the Exome Aggregation Conso rtium (ExAC, http://exac.broadinstitute.org; dbSNP rs769433759); however, its fr equency is low enough to be consistent with a recessive carrier frequency. This variant occurs in the invariant region (+/- 1/2) of the splice consensus sequenc e and is predicted to cause altered splicing leading to an abnormal or absent pr otein. Furthermore, RT-PCR analysis performed on RNA extracted from nasal epith elial cells from one patient showed aberrant splicing resulting in a truncated p rotein (Aparisi 2013). Loss of function of the CDH23 gene is an established dise ase mechanism in autosomal recessive Usher syndrome. In summary, this variant m eets our criteria to be classified as pathogenic for Usher syndrome in an autoso mal recessive manner based on the predicted impact of the variant. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at